Company Monitoring Page for Gilead

latest headlines for company on cafepharma

Shares of hepatitis C drug developers rise on Bristol-Myers' $2.5B deal for Inhibitex
Yahoo/AP
Mon, 01/9/12 - 09:57 am
Tags:
hepatitis C, Bristol-Myers Squibb, M&A, Inhibitex, Gilead, Pharmasset
The Magic Formula for Biotech
Motley Fool
Sun, 01/8/12 - 12:50 pm
Tags:
Gilead, Amgen
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Tags:
Celgene, Vivus, Dendreon, Gilead, Incyte, YM BioSciences, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Amarin, Biomarin, Biogen Idec, Regeneron, Merck KGaA, Human Genome Sciences, Clovis Oncology, Roche, Ariad, Immunogen, Medivation, Geron, InterMune, Indenix, Amag Pharmaceuticals, Mesoblast, Arena, MannKind, Keryx, Spectrum Pharmaceuticals
Pharmasset: M&A Presents Interesting Options Plays
Seeking Alpha
Wed, 01/4/12 - 09:36 am
Tags:
M&A, Pharmasset, Gilead
Fate on Gilead Quad Set for Aug '12
Yahoo/Zacks
Wed, 12/28/11 - 06:15 pm
Tags:
Quad, Gilead, HIV, FDA
Pharma winners of 2011 could keep surging next year
Investorplace
Wed, 12/28/11 - 12:08 pm
Tags:
Amgen, Biogen Idec, Celgene, Gilead, Pharmasset, Alexion, Regeneron
Recent Performance Review Of 5 Large Cap Biotech Equities
Seeking Alpha
Tue, 12/27/11 - 12:36 pm
Tags:
Alexion, Amgen, Biogen Idec, Celgene, Gilead, Merck, Pfizer
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Tags:
Oncothyreon, Keryx, Vical, Aeterna Zentaris, Eli Lilly, JNJ, Elan, Celgene, Pfizer, Gilead, Pharmasset, Threshold Pharmaceuticals, Celldex, Amgen, BioVex, Aveo Pharmaceutical, Amylin, Alkermes, Vertex, Cell Therapeutics, Amarin, ONYX Pharmaceuticals, Vivus
4 Biotech Stocks With Consistently Rising EPS
Seeking Alpha
Thu, 12/22/11 - 09:16 am
Tags:
Amgen, Biogen Idec, Gilead, Illumina
Health Care's Hottest Duo
Motley Fool
Wed, 12/21/11 - 09:01 am
Tags:
Gilead, Pharmasset, hepatitis C, Achillion, Inhibitex
Gilead Sciences And Its HIV Prevention-In-A-Pill
Pharmalot
Mon, 12/19/11 - 10:03 am
Tags:
HIV, Gilead, Truvada
Hep C Drug Panic! Pharmasset Stumble Ripples Through Sector
TheStreet.com
Fri, 12/16/11 - 11:29 am
Tags:
Pharmasset, hepatitis C, Gilead, Inhibitex, PSI-938, Indenix
Pharmasset Says Drug Trial Change Won’t Affect Gilead Takeover Agreement
Bloomberg
Fri, 12/16/11 - 11:26 am
Tags:
Pharmasset, Gilead, M&A, hepatitis C, PSI-938
Gilead Reports Non-inferior Data From Phase 3 Study Of Elvitegravir In HIV
NASDAQ.com
Fri, 12/9/11 - 12:02 pm
Tags:
HIV, Gilead, elvitegravir
4 Reasons Inhibitex Is No Longer A Good Buy
Seeking Alpha
Wed, 12/7/11 - 11:42 am
Tags:
Inhibitex, INX-189, Gilead, hepatitis C, Pharmasset
Pharmasset Poised to Pay 20% on Gilead Closing in First Quarter: Real M&A
Bloomberg
Mon, 12/5/11 - 10:14 pm
Tags:
Pharmasset, Gilead, M&A, PSI-7977, hepatitis C
Why Large Cap Healthcare Multiples Should Expand
Seeking Alpha
Thu, 12/1/11 - 12:10 pm
Tags:
Abbott Laboratories, Gilead, JNJ, Merck, Medtronic, Medicis, Pfizer
5 Risky Biotechs With Serious Profit Potential
Seeking Alpha
Tue, 11/29/11 - 01:37 pm
Tags:
Amgen, Gilead, Spectrum Pharmaceuticals, InterMune, ViroPharma
Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020
Seeking Alpha
Mon, 11/28/11 - 11:38 am
Tags:
Gilead, Pharmasset, M&A, hepatitis C, GSK, JNJ, Bristol-Myers Squibb, PSI-7977, Vertex, HIV
Gilead could have had Pharmasset cheap: founder
Reuters
Wed, 11/23/11 - 09:23 am
Tags:
Pharmasset, Gilead, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.